| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC11854 | IDX899 | A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively. |
|
| DC9029 | Abacavir | Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
|
| DC7058 | Amprenavir Featured | Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection. |
|
| DC3150 | Atazanavir Featured | Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM. |
|
| DC9480 | Atazanavir (sulfate) | Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor. |
|
| DC10890 | Bictegravir Featured | Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM. |
|
| DC9700 | BMS-707035 Featured | BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity. |
|
| DC2046 | Cobicistat (GS-9350) Featured | Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM. |
|
| DC8908 | Darunavir ethanolate Featured | Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2). |
|
| DC11352 | Delavirdine (mesylate) | Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively). |
|
| DC8897 | Delavirdine | Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI). |
|
| DC7273 | Dolutegravir Featured | Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. |
|
| DC10250 | Dolutegravir Sodium Featured | Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM. |
|
| DC9308 | Doravirine (MK-1439) Featured | Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor. |
|
| DCAPI1479 | Efavirenz | Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip |
|
| DC5902 | Emtricitabine Featured | Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve |
|
| DC4234 | Etravirine | Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1). |
|
| DCAPI1505 | Darunavir Featured | Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) . |
|
| DC9476 | NBD-556 Featured | NBD-556 is small molecule mimetic of CD4, NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. |
|
| DC9477 | NBD-557 | NBD-557 is a potentially HIV-1 inhibitor. |
|
| DC10355 | Nelfinavir Featured | Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
|
| DC9474 | Nelfinavir (Mesylate) | Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
|
| DC9019 | Nevirapine | Nevirapine is a potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of HIV-1 infection and AIDS. |
|
| DC9479 | Raltegravir (potassium salt) | Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. |
|
| DCAPI1581 | Raltegravir Featured | Raltegravir Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
|
| DC7266 | Rilpivirine(R 278474, TMC 278) Featured | Rilpivirine(R 278474, TMC 278) is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). |
|
| DC9475 | Ritonavir Featured | Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS,showed potent activity against COVID-19(SARS-COV-2) . |
|
| DC8627 | Saquinavir Featured | Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy. |
|
| DC8628 | Saquinavir Mesylate Featured | Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy. |
|
| DC9864 | Azidothymidine (AZT) | Selective reverse transcriptase inhibitor. Exhibits 100-fold selectivity for HIV reverse transcriptase over DNA polymerase α. |
|
